Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. The Company's programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene also invests in novel technologies to develop treatments for diseases not well served by gene therapy.